Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference112 articles.
1. Cazzola M. Myelodysplastic Syndromes. N Engl J Med. 2020;383(14):1358–74. https://doi.org/10.1056/NEJMra1904794.
2. Zeidan AM, Shallis RM, Wang R, Davidoff A, Ma X. Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it. Blood Rev. 2019;34:1–15. https://doi.org/10.1016/j.blre.2018.09.001.
3. Swerdlow SH, Campo E, Lee Harris N, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon (France): International Agency for Research on Cancer; 2017.
4. Ogawa S. Genetics of MDS. Blood. 2019;133(10):1049–59. https://doi.org/10.1182/blood-2018-10-844621.
5. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6):2079–88.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献